MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, SPTX had $6,867K increase in cash & cash equivalents over the period. -$20,172K in free cash flow.

Cash Flow Overview

Change in Cash
$6,867K
Free Cash flow
-$20,172K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from maturities of inve...
    • Accounts payable
    • Prepaid expenses and other curre...
    • Others
Negative Cash Flow Breakdown
    • Purchase of investments
    • Net loss
    • Accrued expenses and other curre...
    • Others

Cash Flow
2026-03-31
Net loss
-25,408
Stock-based compensation expense
2,569
Depreciation expense
26
Amortization of operating lease right-of-use assets
331
Net amortization of premium and discounts on investments
-223
Prepaid expenses and other current assets
-1,571
Other non-current assets
0
Accounts payable
2,780
Related party payable
4
Accrued expenses and other current liabilities
-1,499
Operating lease liability
-323
Net cash used in operating activities
-20,172
Purchase of investments
47,150
Proceeds from maturities of investments
75,000
Purchases of property and equipment
0
Net cash provided (used in) investing activities
27,850
Payment of deferred offering costs
783
Net cash used in financing activities
-783
Effect of exchange rates on cash and cash equivalents
-28
Net increase (decrease) in cash and cash equivalents
6,867
Cash, cash equivalents, and restricted cash, beginning of period
46,496
Cash, cash equivalents, and restricted cash, end of period
53,363
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from maturitiesof investments$75,000K Net cash provided(used in) investing...$27,850K Canceled cashflow$47,150K Net increase(decrease) in cash and cash...$6,867K Canceled cashflow$20,983K Purchase of investments$47,150K Accounts payable$2,780K Stock-based compensationexpense$2,569K Prepaid expenses andother current assets-$1,571K Amortization of operatinglease right-of-use...$331K Depreciation expense$26K Related party payable$4K Net cash used inoperating activities-$20,172K Net cash used infinancing activities-$783K Effect of exchangerates on cash and cash...-$28K Canceled cashflow$7,281K Net loss-$25,408K Payment of deferredoffering costs$783K Accrued expenses andother current...-$1,499K Operating lease liability-$323K Net amortization ofpremium and discounts on...-$223K

Seaport Therapeutics, Inc. (SPTX)

Seaport Therapeutics, Inc. (SPTX)